Tissue/NN
factor/NN
expression/NN
of/IN
human/JJ
monocytes/NNS
is/VBZ
suppressed/VBN
by/IN
lysophosphatidylcholine/NN
./.

The/DT
expression/NN
of/IN
tissue/NN
factor/NN
(/(
TF/NN
)/)
,/,
the/DT
principal/JJ
initiator/NN
of/IN
coagulation/NN
,/,
is/VBZ
increased/VBN
during/IN
inflammation/NN
and/CC
atherosclerosis/NN
./.
=====
Both/DT
conditions/NNS
are/VBP
promoted/VBN
by/IN
lysophosphatidylcholine/NN
(/(
lysoPC/NN
)/)
./.
=====
We/PRP
observed/VBD
in/IN
the/DT
present/JJ
study/NN
that/IN
lysoPC/NN
(/(
1/CD
to/TO
10/CD
micromol/L/NN
)/)
dose-dependently/RB
reduced/VBD
TF/NN
activity/NN
in/IN
human/JJ
monocytes/NNS
,/,
as/IN
elicited/VBN
by/IN
lipopolysaccharide/NN
(/(
LPS/NN
)/)
./.
=====
Lysophosphatidylethanolamine/NN
(/(
lysoPE/NN
)/)
and/CC
other/JJ
lysophospholipids/NNS
did/VBD
not/RB
affect/VB
LPS-induced/JJ
TF/NN
activity/NN
of/IN
human/JJ
monocytes/NNS
./.
=====
TF/NN
antigen/NN
expression/NN
as/IN
elicited/VBN
by/IN
LPS/NN
was/VBD
also/RB
lowered/VBN
by/IN
lysoPC/NN
./.
=====
Phospholipid/NN
analyses/NNS
indicated/VBD
a/DT
selective/JJ
increase/NN
in/IN
the/DT
lysoPC/NN
content/NN
of/IN
the/DT
monocytes/NNS
after/IN
preincubation/NN
with/IN
the/DT
lysophospholipid/NN
./.
=====
LysoPC/NN
inhibited/VBD
the/DT
TF/NN
activity/NN
of/IN
Mono/NN
Mac-6/NN
cells/NNS
to/TO
a/DT
similar/JJ
extent/NN
as/IN
in/IN
the/DT
monocytes/NNS
./.
=====
LPS/NN
binding/NN
to/TO
plasma/NN
membrane/NN
receptors/NNS
and/CC
internalization/NN
of/IN
LPS/NN
into/IN
monocytes/NNS
were/VBD
not/RB
affected/VBN
by/IN
lysoPC/NN
./.
=====
In/IN
contrast/NN
,/,
LPS-mediated/JJ
nuclear/JJ
binding/NN
of/IN
nuclear/JJ
factor-kappaB/Rel/NN
to/TO
a/DT
TF-specific/JJ
kappaB/NN
site/NN
was/VBD
inhibited/VBN
by/IN
lysoPC/NN
./.
=====
Induction/NN
of/IN
TF/NN
mRNA/NN
expression/NN
by/IN
LPS/NN
tended/VBD
to/TO
be/VB
partially/RB
reduced/VBN
by/IN
the/DT
lysophospholipid/NN
./.
=====
Preincubation/NN
with/IN
lysoPC/NN
increased/VBD
monocytic/JJ
cAMP/NN
levels/NNS
./.
=====
Inhibition/NN
of/IN
adenylyl/JJ
cyclase/NN
by/IN
pretreatment/NN
with/IN
2'-deoxy-3'-adenosine/JJ
monophosphate/NN
partially/RB
reversed/VBD
the/DT
inhibition/NN
of/IN
TF/NN
activity/NN
promoted/VBN
by/IN
lysoPC/NN
./.
=====
In/IN
conclusion/NN
,/,
lysoPC/NN
markedly/RB
decreases/VBZ
LPS-mediated/JJ
TF/NN
expression/NN
of/IN
human/JJ
monocytes/NNS
,/,
the/DT
effect/NN
probably/RB
being/VBG
mediated/VBN
by/IN
both/CC
transcriptional/JJ
and/CC
posttranscriptional/JJ
mechanisms/NNS
./.
=====
LysoPC/NN
may/MD
thus/RB
attenuate/VB
activation/NN
of/IN
coagulation/NN
during/IN
inflammation/NN
and/CC
atherosclerosis/NN
./.